• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ARCHITECT INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ARCHITECT INSULIN Back to Search Results
Catalog Number 08K41-26
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Patient identifier whole sid (b)(6).An evaluation is in process.
 
Event Description
The customer observed falsely elevated insulin patient results generated using the architect insulin reagents.The following data was provided (uu/ml).Sid (b)(6) result 72.80.Previous results for the patient were provided, 27.4, 34.7.Dilution linearity testing results ranged from 21.60 to 28.80.The patient is an (b)(6) weighing less than (b)(6).The mother of the (b)(6) is a diabetic patient.No impact to patient management was reported.
 
Manufacturer Narrative
Evaluation of the customer issue included a review of the complaint text, a search for similar complaints, a review of field data, a review of labeling, and accuracy testing.No adverse trend was identified for the customer's issue.Review of field data found the complaint lot performance was comparable to other lots, and no issue was found.Labeling was reviewed and found to be adequate.Device history review did not identify any issues that may have caused the customer issue.The product was not available for return.An internal panel was tested with retained kits of the likely cause reagent lot and accuracy testing met all specifications.Based on all available information and abbott diagnostics complaint investigation, the assay performed as intended and no product deficiency was identified.
 
Manufacturer Narrative
The device evaluation was reassessed and concluded that a malfunction occurred, the device did not perform as intended.However, no systematic issue or product deficiency was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT INSULIN
Type of Device
INSULIN
Manufacturer (Section D)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 3500
Manufacturer (Section G)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064 3500
Manufacturer Contact
noemi romero-kondos, rn bsn
100 abbott park road
dept. 09b9, lccp1-3
abbott park, IL 60064-3537
224667-512
MDR Report Key5869475
MDR Text Key51938007
Report Number1415939-2016-00082
Device Sequence Number1
Product Code CFP
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 05/09/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/11/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/17/2016
Device Catalogue Number08K41-26
Device Lot Number61020LP77
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/09/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/01/2016
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age9 DA
-
-